Skip to main content

Main menu

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • ERS Guidelines
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • ERS Guidelines
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Subscriptions

Bronchodilators

  • Seasonal variation in COPD exacerbation rates: budesonide/glycopyrronium/formoterol metered dose inhaler (BGF MDI) at two ICS dose levels in the ETHOS trial
    Gary T. Ferguson, Klaus F. Rabe, Fernando J. Martinez, Chen Wang, Dave Singh, Jadwiga A. Wedzicha, Roopa Trivedi, Earl St Rose, Shaila Ballal, Julie Mclaren, Patrick Darken, Magnus Aurivillius, Colin Reisner, Paul Dorinsky
    European Respiratory Journal Sep 2020, 56 (suppl 64) 5238; DOI: 10.1183/13993003.congress-2020.5238
  • Late Breaking Abstract - Real-world evidence of dual bronchodilator therapy using Clinical COPD Questionnaire in 4700 COPD patients
    Arschang Valipour, Sergey Avdeev, Adam Barczyk, Valentina Bayer, Zvi Fridlender, Mariela Georgieva, Ondřej Kudela, Alexey Medvedchikov, Ramona Miron, Maria Sanzharovskaya, Virginija Šileikienė, Jurij Šorli, Marc Spielmanns, Zsuzsanna Szalai
    European Respiratory Journal Sep 2020, 56 (suppl 64) 5231; DOI: 10.1183/13993003.congress-2020.5231
  • Late Breaking Abstract - COPD exacerbation benefits relative to pneumonia risk with budesonide/glycopyrronium/formoterol metered dose inhaler: analyses from ETHOS
    Klaus F. Rabe, Fernando J. Martinez, Gary T. Ferguson, Dave Singh, Jadwiga A. Wedzicha, Martin Jenkins, Magnus Aurivillius, Colin Reisner, Paul Dorinsky
    European Respiratory Journal Sep 2020, 56 (suppl 64) 5230; DOI: 10.1183/13993003.congress-2020.5230
  • Development of lung function in “healthy” preterm infants during the first six years of life
    Laura Camats Marsol, Inés De Mir Mesa, Olaia Sardón Prado, Paula Corcuera Elosegui, Ignacio Iglesias Serrano, Sandra Rovira Amigó, Javier Korta Murua, Antonio Moreno Galdó
    European Respiratory Journal Sep 2020, 56 (suppl 64) 3950; DOI: 10.1183/13993003.congress-2020.3950
  • The effect of Clip-tone® and its smartphone application on optimization of metered-dose inhaler inhalation technique
    Waleed Wael, Mark J Sanders, Raghda R.S. Hussein, Rania M. Sarhan, Waleed Ramadan, Mohamed Abdelrahim
    European Respiratory Journal Sep 2020, 56 (suppl 64) 4157; DOI: 10.1183/13993003.congress-2020.4157
  • Comparison of a dry powder inhaler (DPI) to a pressurized metered-dose inhaler (pMDI) formulation of extra fine beclomethasone dipropionate/formoterol fumarate/glycopyrronium bromide (BDP/FF/GB) in patients with COPD: The TRI-D study
    Kai Michael Beeh, Piotr Kuna, Isabelle Viaud, Alessandro Guasconi, Massimo Corradi, George Georges
    European Respiratory Journal Sep 2020, 56 (suppl 64) 3246; DOI: 10.1183/13993003.congress-2020.3246
  • Bronchodilator response in healthy subjects
    Matthew Hegewald, Robert Jensen
    European Respiratory Journal Sep 2020, 56 (suppl 64) 3207; DOI: 10.1183/13993003.congress-2020.3207
  • Closing volume predicts the FEV1 response to bronchodilators in patients with COPD
    Dejan Radovanovic, Matteo Pecchiari, Marina Saad, Pierachille Santus
    European Respiratory Journal Sep 2020, 56 (suppl 64) 3082; DOI: 10.1183/13993003.congress-2020.3082
  • Arrhythmogenic and chronotropic effects of bronchodilator drugs on human cardiomyocytes
    Martin Ščurek, Martin Pešl, Jan Přibyl, Šimon Klimovič, Tomáš Urban, Šárka Jelínková, Vladimír Rotrekl, Kristián Brat
    European Respiratory Journal Sep 2020, 56 (suppl 64) 3297; DOI: 10.1183/13993003.congress-2020.3297
  • In vitro fine particle dose of drug formulation used in asthma & COPD
    Lois Slator, Dirk Von Hollen, Lucy E. A. Hardaker
    European Respiratory Journal Sep 2020, 56 (suppl 64) 3185; DOI: 10.1183/13993003.congress-2020.3185

Pages

  • Previous
  • Next
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • …
  • 48
  • Acute lung injury and critical care (82)
  • Asthma and allergy (662)
  • CF and non-CF bronchiectasis (278)
  • COPD and smoking (909)
  • Epidemiology, occupational and environmental lung disease (214)
  • Genetics (60)
  • Interstitial and orphan lung disease (499)
  • Lung biology and experimental studies (318)
  • Lung cancer (282)
  • Lung imaging (45)
  • Lung structure and function (303)
  • Mechanisms of lung disease (145)
  • Paediatric pulmonology (394)
  • Pulmonary pharmacology and therapeutics (141)
  • Pulmonary vascular disease (523)
  • Respiratory clinical practice (171)
  • Respiratory infections and tuberculosis (973)
  • Sleep medicine (267)

Custom Text goes here

  • Most Read
  • Twitter
Loading
  • Pulsus paradoxus
  • ERS/ATS technical standard on interpretive strategies for routine lung function tests
  • European Respiratory Society guidelines for the diagnosis of asthma in adults
  • The association between SARS-CoV-2 RT-PCR cycle threshold and mortality in a community cohort
  • ERS clinical practice guidelines on treatment of sarcoidosis
More...

Navigate

  • Home
  • Current issue
  • Archive

About the ERJ

  • Journal information
  • Editorial board
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Publication ethics and malpractice
  • Submit a manuscript

For readers

  • Alerts
  • Subjects
  • Podcasts
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Print ISSN:  0903-1936
Online ISSN: 1399-3003

Copyright © 2023 by the European Respiratory Society